113 related articles for article (PubMed ID: 26234343)
1. Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains.
Yao Z; Peng Y; Bi J; Xie C; Chen X; Li Y; Ye X; Zhou J
Epidemiol Infect; 2016 Mar; 144(4):856-63. PubMed ID: 26234343
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of metallo β-lactamase producing multidrug resistant Pseudomonas aeruginosa from various clinical samples.
Ramakrishnan K; Rajagopalan S; Nair S; Kenchappa P; Chandrakesan SD
Indian J Pathol Microbiol; 2014; 57(4):579-82. PubMed ID: 25308010
[TBL] [Abstract][Full Text] [Related]
3. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study.
Peng Y; Bi J; Shi J; Li Y; Ye X; Chen X; Yao Z
Am J Infect Control; 2014 Dec; 42(12):1308-11. PubMed ID: 25444305
[TBL] [Abstract][Full Text] [Related]
4. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
Lee JY; Ko KS
Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
Nouér SA; Nucci M; de-Oliveira MP; Pellegrino FL; Moreira BM
Antimicrob Agents Chemother; 2005 Sep; 49(9):3663-7. PubMed ID: 16127037
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
Obritsch MD; Fish DN; MacLaren R; Jung R
Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital.
Jayakumar S; Appalaraju B
Indian J Pathol Microbiol; 2007 Oct; 50(4):922-5. PubMed ID: 18306607
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
[TBL] [Abstract][Full Text] [Related]
9. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
Cho HH; Kwon GC; Kim S; Koo SH
J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
[TBL] [Abstract][Full Text] [Related]
10. Molecular investigation of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa isolated clinically in Thailand.
Khuntayaporn P; Montakantikul P; Santanirand P; Kiratisin P; Chomnawang MT
Microbiol Immunol; 2013 Mar; 57(3):170-8. PubMed ID: 23278679
[TBL] [Abstract][Full Text] [Related]
11. Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.
Fuse K; Fujimura S; Kikuchi T; Gomi K; Iida Y; Nukiwa T; Watanabe A
J Infect Chemother; 2013 Feb; 19(1):82-8. PubMed ID: 22865331
[TBL] [Abstract][Full Text] [Related]
12. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis.
Matos ECO; Andriolo RB; Rodrigues YC; Lima PDL; Carneiro ICDRS; Lima KVB
Rev Soc Bras Med Trop; 2018; 51(4):415-420. PubMed ID: 30133622
[TBL] [Abstract][Full Text] [Related]
13. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
[TBL] [Abstract][Full Text] [Related]
14. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD.
Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S
J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142
[TBL] [Abstract][Full Text] [Related]
15. Efflux system overexpression and decreased OprD contribute to the carbapenem resistance among extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa isolates from a Chinese university hospital.
Liu Y; Li XY; Wan LG; Jiang WY; Li FQ; Yang JH
Microb Drug Resist; 2013 Dec; 19(6):463-8. PubMed ID: 23865862
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
[TBL] [Abstract][Full Text] [Related]
17. Molecular typing and resistance mechanisms of carbapenem resistant Pseudomonas aeruginosa isolated from a Chinese surgical intensive care unit.
Yi M; Wang P; Liu Y
Chin Med J (Engl); 2014; 127(6):1071-6. PubMed ID: 24622437
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
Wang J; Zhou JY; Qu TT; Shen P; Wei ZQ; Yu YS; Li LJ
Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
[TBL] [Abstract][Full Text] [Related]
20. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
